{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001844417","name":"Estrella Immunopharma, Inc.","summary":"Estrella Immunopharma, Inc. is a clinical-stage biopharmaceutical company developing T-cell therapies for cancers and autoimmune diseases. The company leverages its proprietary ARTEMIS T Cell Receptor Platform to engineer T cells designed to overcome limitations of traditional CAR-T therapies, such as high toxicity and cost. Its lead product candidate, EB103, is being advanced in conjunction with CF33-CD19t, with manufacturing and R&D support provided by Eureka Therapeutics under a Services Agreement.","people":[],"products":[{"name":"EB103","type":"platform","description":"Lead product candidate T-cell therapy being developed for cancers and autoimmune diseases, used in conjunction with CF33-CD19t."},{"name":"ARTEMIS T Cell Receptor Platform","type":"platform","description":"Proprietary cellular engineering platform designed to create T-cell therapies with improved safety and efficacy over traditional CAR-T therapies."},{"name":"CF33-CD19t","type":"platform","description":"Oncolytic virus candidate used in conjunction with EB103 as part of Estrella's combination therapy approach."}],"partnerships":[{"partner_name":"Eureka Therapeutics, Inc.","partnership_type":"licensing","description":"Sole supplier of clinical drug product; provides manufacturing, R&D support, and IT systems under a Services Agreement; holds more than 50% of Estrella's voting power.","start_date":null},{"partner_name":"Imugene","partnership_type":"development","description":"Collaborator involved in conducting preclinical studies and clinical trials for Estrella's product candidates.","start_date":null}],"affiliations":[],"origin":{"leaf":"2e376c7a54bdaeffa922f222251874859cfd1bd8fdbbb2e066ea1bc6200c3611","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"8efa126c26fd7a28096718d2afc4f3324e7d87352aff121b9a58d15d63e1d92a","parent":"73895a1703b089270eb3e3ada51419ab9ef5f13478a3e31ef1b7d6f96599bb83","source":"0001213900-26-029357","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":67,"hourly_limit":500,"remaining":433,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}